{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:47:31Z","timestamp":1777315651798,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00592-019-01370-1","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:02:54Z","timestamp":1559815374000},"page":"117-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The \u03b2-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4107-196X","authenticated-orcid":false,"given":"Carla","family":"Carnovale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Dassano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Mosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faizan","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"D\u2019Addio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Radice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"6","key":"1370_CR1","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2337\/dc14-0396","volume":"37","author":"PA Halban","year":"2014","unstructured":"Halban PA, Polonsky KS, Bowden DW et al (2014) Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37(6):1751\u20131758","journal-title":"Diabetes Care"},{"issue":"1","key":"1370_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.2337\/diabetes.50.2007.S58","volume":"50","author":"T Mandrup-Poulsen","year":"2001","unstructured":"Mandrup-Poulsen T (2001) Beta-cell apoptosis: stimuli and signaling. Diabetes 50(1):S58\u2013S63","journal-title":"Diabetes"},{"issue":"3","key":"1370_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1124\/mol.112.078253","volume":"82","author":"H Cha-Molstad","year":"2012","unstructured":"Cha-Molstad H, Xu G, Chen J et al (2012) Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes. Mol Pharmacol 82(3):541\u2013549","journal-title":"Mol Pharmacol"},{"issue":"5","key":"1370_CR4","doi-asserted-by":"publisher","first-page":"E1133","DOI":"10.1152\/ajpendo.90944.2008","volume":"296","author":"J Chen","year":"2009","unstructured":"Chen J, Cha-Molstad H, Szabo A, Shalev A (2009) Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. Am J Physiol Endocrinol Metab 296(5):E1133\u2013E1139","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1370_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2337\/db11-0955","volume":"61","author":"G Xu","year":"2012","unstructured":"Xu G, Chen J, Jing G, Shalev A (2012) Preventing b-cell loss and diabetes with calcium channel blockers. Diabetes 61(4):848\u2013856","journal-title":"Diabetes"},{"key":"1370_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2018.04.002","volume":"830","author":"DS Carvalho","year":"2018","unstructured":"Carvalho DS, Aparecido de Almeida A, Ferreira Borges A, Vannucci C (2018) Treatments for diabetes mellitus type II: new perspectives regarding the possible role of calcium and cAMP interaction. Eur J Pharmacol 830:9\u201316","journal-title":"Eur J Pharmacol"},{"key":"1370_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","volume":"115","author":"Y Khodneva","year":"2016","unstructured":"Khodneva Y, Shalev A, Frank SJ, Carson AP, Safford MM (2016) Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study. Diabetes Res Clin Pract 115:115\u2013121","journal-title":"Diabetes Res Clin Pract"},{"issue":"5 Pt 1","key":"1370_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0895-7061(03)00062-1","volume":"16","author":"H Holzgreve","year":"2003","unstructured":"Holzgreve H, Nakov R, Beck K, Janka HU (2003) Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Am J Hypertens 16(5 Pt 1):381\u2013386","journal-title":"Am J Hypertens"},{"issue":"7","key":"1370_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.amjcard.2006.04.030","volume":"98","author":"R Cooper-Dehoff","year":"2006","unstructured":"Cooper-Dehoff R, Cohen JD, Bakris GL et al (2006) Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]). Am J Cardiol 98(7):890\u2013894","journal-title":"Am J Cardiol"},{"issue":"5","key":"1370_CR10","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ahj.2005.05.024","volume":"151","author":"RM Cooper-DeHoff","year":"2006","unstructured":"Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E et al (2006) Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients\u2013findings from the International Verapamil SR\/Trandolapril Study (INVEST). Am Heart J 151(5):1072\u20131079","journal-title":"Am Heart J"},{"issue":"7","key":"1370_CR11","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1210\/jc.2016-3778","volume":"102","author":"T Yin","year":"2017","unstructured":"Yin T, Kuo SC, Chang YY, Chen YT, Wang KK (2017) Verapamil use is associated with reduction of newly diagnosed diabetes mellitus. J Clin Endocrinol Metab 102(7):2604\u20132610","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1370_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ceca.2013.06.004","volume":"54","author":"LB Bergantin","year":"2013","unstructured":"Bergantin LB, Souza CF, Ferreira RM et al (2013) Novel model for \u201ccalcium paradox\u201d in sympathetic transmission of smooth muscles: role of cyclic AMP pathway. Cell Calcium 54(3):202\u2013212","journal-title":"Cell Calcium"},{"issue":"5","key":"1370_CR13","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1002\/prp2.181","volume":"3","author":"A Caricati-Neto","year":"2015","unstructured":"Caricati-Neto A, Garc\u00eda AG, Bergantin LB (2015) Pharmacological implications of the Ca2+\/cAMP signaling interaction: from risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders. Pharmacol Res Perspect 3(5):e00181","journal-title":"Pharmacol Res Perspect"},{"key":"1370_CR14","first-page":"253","volume":"3","author":"LB Bergantin","year":"2015","unstructured":"Bergantin LB, Jurkiewicz A, Garc\u00eda AG, Caricati-Neto A (2015) A calcium paradox in the context of neurotransmission. J Pharm Pharmacol 3:253\u2013261","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"1370_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","volume":"13","author":"WJ Elliott","year":"2011","unstructured":"Elliott WJ, Ram CV (2011) Calcium channel blockers. J Clin Hypertens 13(9):687\u2013689","journal-title":"J Clin Hypertens"},{"issue":"6","key":"1370_CR16","first-page":"IV31-9","volume":"80","author":"M Akhtar","year":"1989","unstructured":"Akhtar M, Tchou P, Jazayeri M (1989) Use of calcium channel entry blockers in the treatment of cardiac arrhythmias. Circulation 80(6):IV31-9","journal-title":"Circulation"},{"issue":"2","key":"1370_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-2006-939925","volume":"26","author":"DJ Capobianco","year":"2006","unstructured":"Capobianco DJ, Dodick DW (2006) Diagnosis and treatment of cluster headache. Semin Neurol 26(2):242\u2013259","journal-title":"Semin Neurol"},{"issue":"1","key":"1370_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11940-012-0208-3","volume":"15","author":"N Pelzer","year":"2013","unstructured":"Pelzer N, Stam AH, Haan J, Ferrari MD, Terwindt GM (2013) Familial and sporadic hemiplegic migraine: diagnosis and treatment. Curr Treat Opt Neurol 15(1):13\u201327","journal-title":"Curr Treat Opt Neurol"},{"issue":"5","key":"1370_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","volume":"43","author":"P Verdecchia","year":"2004","unstructured":"Verdecchia P, Reboldi G, Angeli F et al (2004) Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43(5):963\u2013969","journal-title":"Hypertension"},{"key":"1370_CR20","unstructured":"Prospero International Prospective Register of Systematic Reviews. Available from: https:\/\/www.crd.york.ac.uk\/PROSPERO\/ . Accessed 2 June 2018"},{"key":"1370_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"key":"1370_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377\u2013384","journal-title":"J Epidemiol Community Health"},{"issue":"Suppl 1","key":"1370_CR23","first-page":"29","volume":"10","author":"JPT Higgins","year":"2016","unstructured":"Higgins JPT, Sterne JAC, Savovic J et al (2016) A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev 10(Suppl 1):29\u201331","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"1370_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0954-6820.1981.tb09771.x","volume":"210","author":"DEH Andersson","year":"1981","unstructured":"Andersson DEH, Rojdmark S (1981) Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus. Acta Med Scand 210(1\u20132):27\u201333","journal-title":"Acta Med Scand"},{"issue":"1","key":"1370_CR25","first-page":"35","volume":"3","author":"MC Chellingsworth","year":"1989","unstructured":"Chellingsworth MC, Kendall MJ, Wright AD, Singh BM, Pasi J (1989) The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus. J Hum Hypertens 3(1):35\u201339","journal-title":"J Hum Hypertens"},{"issue":"5","key":"1370_CR26","first-page":"843","volume":"49","author":"G Cortassa","year":"1991","unstructured":"Cortassa G, Borgoglio A, Civelli D et al (1991) Effects of antihypertensive therapy with verapamil on glucose tolerance and insulin secretion in type II diabetics. Curr Ther Rese Clin Exp 49(5):843\u2013853","journal-title":"Curr Ther Rese Clin Exp"},{"issue":"12","key":"1370_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.jhh.1001279","volume":"15","author":"R Fern\u00e1ndez","year":"2001","unstructured":"Fern\u00e1ndez R, Puig JG, Rodr\u00edguez-P\u00e9rez JC, Garrido J, Redon J, TRAVEND Study Group (2001) Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study. J Hum Hypertens 15(12):849\u2013856","journal-title":"J Hum Hypertens"},{"issue":"10","key":"1370_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2337\/diacare.14.10.911","volume":"14","author":"C Ferrier","year":"1991","unstructured":"Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta-Piccoli C, Riesen WF (1991) Antihypertensive therapy with Ca2+. Antagonist verapamil and\/or ACE inhibitor enalapril in NIDDM patients. Diabetes Care 14(10):911\u2013914","journal-title":"Diabetes Care"},{"issue":"2","key":"1370_CR29","first-page":"170","volume":"22","author":"I Goicolea","year":"2002","unstructured":"Goicolea I, Fern\u00e1ndez Gonz\u00e1lez R, Pini\u00e9s J et al (2002) Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study. Nefrologia 22(2):170\u2013178","journal-title":"Nefrologia"},{"issue":"12","key":"1370_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1055\/s-2007-1019369","volume":"13","author":"S R\u00f6jdmark","year":"1981","unstructured":"R\u00f6jdmark S, Andersson DE, Hed R, Sundblad L (1981) Calcium-antagonistic effects on glucose response to glucagon in patients with non-insulin-dependent diabetes mellitus and in normoglycemic subjects. Horm Metab Res 13(12):664\u2013667","journal-title":"Horm Metab Res"},{"key":"1370_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.0954-6820.1984.tb08675.x","volume":"681","author":"S R\u00f6jdmark","year":"1984","unstructured":"R\u00f6jdmark S, Andersson DE (1984) Influence of verapamil on glucose tolerance. Acta Med Scand Suppl 681:37\u201342","journal-title":"Acta Med Scand Suppl"},{"issue":"7","key":"1370_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2337\/diacare.27.7.1688","volume":"27","author":"AF Rubio-Guerra","year":"2004","unstructured":"Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriguez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT (2004) The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes. Diabetes Care 27(7):1688\u20131691","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"1370_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/00003495-199200441-00015","volume":"44","author":"J Lyngs\u00f8e","year":"1992","unstructured":"Lyngs\u00f8e J, S\u00f8rensen M, Sj\u00f8strand H, Sengel\u00f8v H, Thrane MT, Holst J (1992) The effect of sustained release verapamil on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Drugs 44(Suppl 1):85\u201387","journal-title":"Drugs"},{"issue":"5","key":"1370_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00626359","volume":"41","author":"MB Sorensen","year":"1991","unstructured":"Sorensen MB, Sj\u00f8strand H, Sengel\u00f8v H, Tiefenthal M, Holst J, Lyngs\u00f8e J (1991) Influence of short term verapamil treatment on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Eur J Clin Pharmacol 41(5):401\u2013404","journal-title":"Eur J Clin Pharmacol"},{"issue":"1\u20132","key":"1370_CR35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0954-6820.1982.tb01899.x","volume":"211","author":"DE Andersson","year":"1982","unstructured":"Andersson DE, R\u00f6jdmark S, Hed R, Sundblad L (1982) Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man. Acta Med Scand 211(1\u20132):35\u201343","journal-title":"Acta Med Scand"},{"issue":"7","key":"1370_CR36","doi-asserted-by":"publisher","first-page":"39d","DOI":"10.1016\/0002-9149(86)90804-0","volume":"57","author":"S Rojdmark","year":"1986","unstructured":"Rojdmark S, Andersson DE (1986) Influence of verapamil on human glucose tolerance. Am J Cardiol 57(7):39d\u201343d","journal-title":"Am J Cardiol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01370-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T06:51:04Z","timestamp":1721371864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01370-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01370-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}